SRNE News and Press, Sorrento Therapeutics Inc. From 07/01/22

Penny stocks continue lighting up the boards as retail traders take a breather from investing and focus on day trading. Whether it’s the latest short squeeze stock or meme stocks to watch, daily trends are plentiful when it comes to capitalizing on short-term moves in the stock marke...

SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial and clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies and diagnostics, announced today the appointment of the...

3 Penny Stocks to Add to Your Watchlist Right Now With another positive day of trading for penny stocks and blue chips, investors are looking for the best penny stocks to buy . Right now, we have several issues at play that are causing movement in the stock market. This includes cli...

Gainers: 22nd Century Group (XXII) +29%. Wave Life Sciences WVE +16%. Codex DNA (DNAY) +13%. F-star Therapeutics (FSTX) +12%. Sorrento Therapeutics (SRNE) +12%. Losers: Athira Pharma ATHA -70%. Neptune Wellness Solutions NEPT -32%. 4D pharma (LBPS)...

Gainers: Convey Health Solutions Holdings (CNVY) +139%. Valneva (VALN) +86%. Green Giant (GGE) +78%. CEA Industries (CEAD) +76%. Clovis Oncology (CLVS) +71%. Tabula Rasa HealthCare (TRHC) +34%. Revlon (REV) +34%. Innate Pharma (IPHA) +33%. Sorrento Therapeutics (SRNE) +28%. MacroGenics (MGNX)...

AC Immune (ACIU) -32%  as crenezumab fails in Alzheimer's study. Cango (CANG) -30%. Absci (ABSI) -14%. Hillstream BioPharma (HILS) -11%. Cepton (CPTN) -7%. Enservco Corporation (ENSV) -10%. Arcellx (ACLX) -10% on upsizing of follow-on public offering of 7M shares at $...

Scilex, a unit of Sorrento Therapeutics (NASDAQ:SRNE), on Tuesday said it had entered into a licensing and commercialization agreement with Romeg Therapeutics for the right to market and distribute in the U.S. Gloperba, an oral solution for gout. Romeg's Gloperba is an FDA-approved,...

Gloperba is an FDA-approved, oral medication for treating painful gout flares in adults. Gout is a painful arthritic disorder affecting an estimated 8.7 million people in the United States 1 . As gout cases increase every year, treatment requirements increase. The gout treatment m...

FTSE Russell has released a preliminary lists of companies set to join or leave the Russell Microcap Index as part of its 2022 annual reconstitution. Notable health care additions include: Inovio Pharma (INO), Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), Ocu...

Sorrento's (NASDAQ:SRNE) subsidiary Scilex Holding on Friday has announced the pre-emptive repurchase of part of its senior secured notes. That allows the pain management company - Scilex - to repurchase $41.4M principal amount of notes on or before Sept. 30, 2022 and the holders of the notes...